ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.

Anthony W Tolcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.